BioCryst Pharmaceuticals, Inc. (BCRX)
9.47
+0.45
(+4.99%)
USD |
NASDAQ |
Apr 06, 16:00
9.47
0.00 (0.00%)
After-Hours: 06:44
BioCryst Pharmaceuticals SG&A Expense (TTM) : 348.65M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Anika Therapeutics, Inc. | 49.09M |
| Lantheus Holdings, Inc. | 453.81M |
| Revolution Medicines, Inc. | 195.04M |
| Plus Therapeutics, Inc. | 12.13M |
| BioStem Technologies, Inc. | 116.97M |